Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 3/20 | 0.33 |
| ▸ | ACHE | P22303 | 3/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18349845 | 0.96 | BCHE (0.34) | BCHEACHEHDAC6 | |
| SCHEMBL18349846 | 0.89 | BCHE (0.36) | BCHEACHEHDAC6 | |
| SCHEMBL16393095 | 0.85 | LMNA (0.33) | BCHEACHEHDAC6 | |
| SCHEMBL18349597 | 0.84 | BCHE (0.37) | BCHEACHEHDAC6 | |
| SCHEMBL18349847 | 0.83 | — | — | |
| SCHEMBL18349592 | 0.79 | BCHE (0.30) | BCHEACHE | |
| SCHEMBL16393094 | 0.78 | LMNA (0.34) | BCHEACHEHDAC6 | |
| SCHEMBL16393093 | 0.74 | — | — | |
| SCHEMBL16392920 | 0.72 | LMNA (0.42) | BCHEACHEHDAC6 | |
| SCHEMBL18349615 | 0.71 | TYMP (0.38) | HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160376585-A1 | OLIGONUCLEOTIDE-LIGAND CONJUGATES AND PROCESS FOR THEIR PREPARATION | BANK OF AMERICA, N.A. | 2016-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160376585-A1 | OLIGONUCLEOTIDE-LIGAND CONJUGATES AND PROCESS FOR THEIR PREPARATION | IGF2R, IRS1, INSR | BCHE 4414/4885ACHE 4533/4885HDAC6 935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.